左心室辅助装置植入前健康相关生活质量评估不完整性:一种新型质量指标
研究基于Intermacs注册系统14,063例初次LVAD植入患者(2012年4月至2017年8月),分析植入前HRQOL(EQ-5D-5L视觉模拟量表与KCCQ-12)数据不完整性的危险因素,并计算医院调整后不完整率。结果显示调整后植入前EQ-5D不完整率每增加10%与感染相关死亡、感染及肾功能不全风险升高显著相关,KCCQ-12不完整率每增加10%与感染风险升高显著相关。医院调整后植入前HRQOL不完整性可预测植入后90天结局,可能作为新型质量指标。
要点
- 植入前HRQOL数据不完整在高不完整率医院更多因行政原因,较少因患者原因。
- 调整后植入前EQ-5D不完整率每增10%,感染相关死亡HR 1.09、感染HR 1.05、肾功能不全HR 1.03。
- 调整后植入前KCCQ-12不完整率每增10%,感染风险HR 1.04。
核心结论
- 医院调整后植入前HRQOL不完整性可预测LVAD植入后90天结局,可能作为新型质量指标。
研究设计与样本
- 研究队列纳入14,063例接受初次LVAD植入的患者(2012年4月至2017年8月),数据来自STS Intermacs注册系统。
- 采用逐步logistic模型分析植入前HRQOL(EQ-5D-5L视觉模拟量表与KCCQ-12)不完整性的危险因素。
- 采用直接标准化法计算调整后不完整率,基于混合效应logistic模型,医院按调整后不完整率中位数二分为低率或高率。
- 采用Andersen-Gill模型分析植入前HRQOL调整后不完整率与植入后90天内不良事件的关联。
主要发现
- 高不完整率医院中,HRQOL不完整更多因行政原因(风险差:EQ-5D 10.1%;KCCQ-12 11.6%),较少因患者原因(风险差:EQ-5D -8.9%;KCCQ-12 -11.4%)。
- 调整后植入前EQ-5D不完整率每增加10%,与感染相关死亡风险升高显著相关(HR 1.09)。
- 调整后植入前EQ-5D不完整率每增加10%,与感染风险升高显著相关(HR 1.05)。
- 调整后植入前EQ-5D不完整率每增加10%,与肾功能不全风险升高显著相关(HR 1.03)。
- 调整后植入前KCCQ-12不完整率每增加10%,与感染风险升高显著相关(HR 1.04)。
临床怎么用
- 作者认为医院调整后植入前HRQOL不完整性可预测植入后90天结局,可能作为新型质量指标。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Improved health-related quality of life (HRQOL) is an important outcome following durable left ventricular assist device (LVAD) implant. However, half of pre-implant HRQOL data are incomplete in The Society of Thoracic Surgeons' Intermacs registry. Pre-implant HRQOL incompleteness may reflect patient status or hospital resources to capture HRQOL data. We hypothesized that pre-implant HRQOL incompleteness predicts 90 day outcomes and serves as a novel quality metric. METHODS: Risk factors for pre-implant HRQOL (EQ-5D-5L visual analog scale; 12-item Kansas City Cardiomyopathy Questionnaire "KCCQ") incompleteness were examined by stepwise logistic modeling. Direct standardization method was used to calculate adjusted incompleteness rates using a mixed effects logistic model. Hospitals were dichotomized as low or high based on median adjusted incompleteness rates. Andersen-Gill models were used to associate pre-implant HRQOL adjusted incompleteness rate with adverse events within 90 day post-implant. RESULTS: The study cohort included 14,063 patients receiving a primary LVAD (4/2012-8/2017). HRQOL incompleteness at high-rate hospitals was more often due to administrative reasons (risk difference, EQ-5D: 10.1%; KCCQ-12: 11.6%) and less likely due to patient reasons (risk difference, EQ-5D: -8.9%; KCCQ-12: -11.4%). A 10% increase in the adjusted pre-implant EQ-5D incompleteness rate was significantly associated with higher risk of infection-related mortality (HR: 1.09), infection (HR: 1.05), and renal dysfunction (HR: 1.03). A 10% increase in the adjusted pre-implant KCCQ-12 incompleteness rate was significantly associated with higher risk of infection (HR: 1.04). CONCLUSIONS: Hospital adjusted pre-implant HRQOL incompleteness was predictive of 90-day post-implant outcomes and may serve as a novel quality metric.
引用
- Yang G, Zhang M, Zhou S, et al. Incompleteness of health-related quality of life assessments before left ventricular assist device implant: A novel quality metric. J Heart Lung Transplant. 2022. PMID: 35961829. doi:10.1016/j.healun.2022.07.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。